Literature DB >> 27164531

Prevalence of Endocrinopathies in Turkish Children With β-Thalassemia Major: A Single-Center Study.

Ayça Altincik1, Mehmet Akin.   

Abstract

Present chelation protocols have increased the life quality and survival of the patients with β-thalassemia major (BTM). However, endocrine complications are still mostly experienced. The aim of this study was to determine the prevalence of endocrine complications in children with BTM, and to study the relationship between serum ferritin levels and complications. Forty-five children (female: 23/male: 22, mean age: 12.39±3.72 y) with BTM were enrolled into the study. Blood samples were taken after an overnight fasting, early in the morning from entire study group. Median (range) serum ferritin of the patients was 1365 ng/mL (362 to 5996 ng/mL). The most prevalent endocrine complications were vitamin D insufficiency (54.5%), short stature (42%), pubertal impairment (25% for each sex), and osteopenia (13%), respectively. Ferritin levels were not correlated with anthropometric or laboratory data. Monitoring of growth, vitamin D status, and endocrine functions are essential to achieve a good quality of life in BTM patients.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27164531     DOI: 10.1097/MPH.0000000000000573

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  5 in total

1.  Prevalence of endocrine disorders and their associated factors in transfusion-dependent thalassemia patients: a historical cohort study in Southern Iran.

Authors:  M Bordbar; H Bozorgi; F Saki; S Haghpanah; M Karimi; A Bazrafshan; O R Zekavat
Journal:  J Endocrinol Invest       Date:  2019-06-21       Impact factor: 4.256

2.  Nutrition in Thalassemia: A Systematic Review of Deficiency, Relations to Morbidity, and Supplementation Recommendations.

Authors:  Elijah K Goldberg; Ashutosh Lal; Ellen B Fung
Journal:  J Pediatr Hematol Oncol       Date:  2022-01-01       Impact factor: 1.289

Review 3.  Elevated Prevalence of Abnormal Glucose Metabolism and Other Endocrine Disorders in Patients with β-Thalassemia Major: A Meta-Analysis.

Authors:  Li-Na He; Wei Chen; Yi Yang; Ying-Jun Xie; Ze-Yu Xiong; Di-Yu Chen; Dian Lu; Neng-Qing Liu; Ying-Hong Yang; Xiao-Fang Sun
Journal:  Biomed Res Int       Date:  2019-04-18       Impact factor: 3.411

4.  An ICET-A survey on occult and emerging endocrine complications in patients with β-thalassemia major: Conclusions and recommendations.

Authors:  Vincenzo De Sanctis; Ashraf T Soliman; Duran Canatan; Ploutarchos Tzoulis; Shahina Daar; Salvatore Di Maio; Heba Elsedfy; Mohamed A Yassin; Aldo Filosa; Nada Soliman; Karimi Mehran; Forough Saki; Praveen Sobti; Shruti Kakkar; Soteroula Christou; Alice Albu; Constantinos Christodoulides; Yurdanur Kilinc; Soad Al Jaouni; Doaa Khater; Saif A Alyaarubi; Su Han Lum; Saveria Campisi; Salvatore Anastasi; Maria Concetta Galati; Giuseppe Raiola; Yasser Wali; Ihab Z Elhakim; Demetris Mariannis; Vassilis Ladis; Christos Kattamis
Journal:  Acta Biomed       Date:  2019-01-15

5.  Evaluation of the vitamin D and biomedical statuses of young children with β-thalassemia major at a single center in southern China.

Authors:  Uet Yu; Li Chen; Xiaodong Wang; Xiaoling Zhang; Yue Li; Feiqiu Wen; Sixi Liu
Journal:  BMC Pediatr       Date:  2019-10-23       Impact factor: 2.125

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.